Sökning: "malignancy grading"
Visar resultat 1 - 5 av 8 avhandlingar innehållade orden malignancy grading.
1. A histopathologic malignancy grading system for indication of prognosis in invasive squamous cell carcinoma of the uterine cervix
Sammanfattning : .... LÄS MER
2. Squamous cell carcinomas and preneoplastic lesions of the oral cavity : biological factors and prognosis
Sammanfattning : In Sweden, squamous cell carcinoma of the oral cavity comprises only 0.8% of the total cancer incidence. However, this disease often has a poor prognosis and the treatment frequently means some degree of disfiguration of the patient. LÄS MER
3. Prognostic Factors in Early Stage Cervical Carcinomas Treated with Wertheim-Meigs Surgery
Sammanfattning : Cervical cancer is the second most common malignancy and a leading cause of morbidity and mortality among women worldwide. In Sweden, cervical cancer constitutes 2.4% of all newly diagnosed cancers and is the fifteenth cause of death.An improved estimation of the prognosis in early stages of cervical carcinomas is desirable. LÄS MER
4. Identification, validation and clinical application of a three-gene signature for accurate prognosis prediction and treatment selection of newly diagnosed prostate cancer
Sammanfattning : This thesis presents a complete, comprehensive and stepwise approach of translational molecular research. Starting from whole-genome bioinformatics analyses based on the embryonic stem (ES) cell hypothesis, a three-gene signature was identified, validated with the goal of clinical application in order to optimize treatment decision based on improvement of overall survival estimation. LÄS MER
5. Validation of Several Nucleoside Tracers as Proliferation Markers
Sammanfattning : Positron emission tomography (PET) is a powerful method for in vivo characterization of tumor biochemistry and clinically has been used for diagnosing and grading of malignancy. A key element in oncology is proliferation potential, a feature that is assumed to be an important indicator of tumor growth. LÄS MER